CClinicalTrials.gg
TerminatedNCT03946709MNOPUpdated Jun 28, 2021

Mirror Neurons in Older Participants

An interventional study of Action Observation in Muscle Weakness, Dynapenia and Sarcopenia, sponsored by University of Central Florida. Terminated at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-28.

Sponsored by University of Central Florida · Not applicable, Interventional, and Basic science

Why this study was terminated
COVID-19 risk in older adults.

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Dec 2018, registered May 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to muscle atrophy, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary muscle activation, and cortical excitability and inhibition in older adults.

Read the detailed description

A critical problem facing aging adults is muscle weakness. Whereas scientists have traditionally attributed the loss of muscle strength with aging to atrophic effects, emerging evidence suggests that impairments in the neuromuscular system's ability to voluntarily generate force plays a more central role than previously appreciated. One area that has not yet been investigated includes the role that observing another's actions - thereby activating mirror neurons - plays in muscle force generation. Therefore, the purpose of this study is to examine the acute effects of action observation on muscular strength, voluntary activation, and cortical excitability and inhibition in older adults. Following a thorough familiarization visit, twenty-five men and women ≥60 years of age will complete three action observation sessions in a randomized, counterbalanced manner: 1) observation of very strong hand/wrist contractions, 2) observation of very weak hand/wrist contractions, and 3) a control condition. Maximal voluntary contractions (MVCs) of the wrist flexors will be performed before and after observation sessions. Percent voluntary activation will be determined via the interpolated twitch technique. Single-pulse transcranial magnetic stimulation (TMS) and electromyographic (EMG) recordings from the flexor carpi radialis and first dorsal interosseous will be used to quantify cortical excitability and inhibition, via motor evoked potential amplitude and silent period duration, respectively. The hypothesis of this study is that observation of strong muscle contractions will acutely increase muscle strength, and such changes will be facilitated by enhanced corticospinal excitability and decreased inhibition. In contrast, it is hypothesized that observation of very weak contractions will cause no such efforts or even acute muscle weakness. Collectively, we propose that manipulation of mirror neurons is a worthwhile strategy for clinicians hoping to induce neuromuscular adaptations in older adults, particularly in settings where movement of a joint is painful or infeasible (e.g., bedrest or immobilization).

02

Conditions studied

  • Muscle Weakness
  • Dynapenia
  • Sarcopenia
03

In context

Muscle Weakness

601 studies on the registry are indexed under Muscle Weakness; 99 are open to participants now.

This study's enrollment of 14 is below the median of 46 across 444 interventional studies indexed under Muscle Weakness.

Browse Muscle Weakness studies →

Lead sponsor

University of Central Florida is the lead sponsor of 99 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy men and women ≥60 years of age

Exclusion criteria

Exclusion Criteria:

  • Neuromuscular disease (e.g. Parkinson's, MS, ALS)
  • Metabolic disease (e.g. diabetes, thyroid disorder, metabolic syndrome)
  • Arthritis in the upper limbs (hands, arms, shoulders)
  • Trouble using or controlling one's muscles
  • History of cancer
  • History of stroke
  • History of heart attack
  • Use of an assistive walking device or other mobility aids
  • Physician mandated contraindication to exercise within the last 6 months
  • Epilepsy or history of convulsions/seizures
  • History of fainting or syncope
  • History of head trauma that was diagnosed as concussion or was associated with loss of consciousness
  • History of hearing problems or tinnitus
  • Cochlear implants
  • Implanted metal in the brain, skull, or elsewhere in the body
  • Implanted neurotransmitter
  • Cardiac pacemaker or intracardiac lines
  • Medication infusion device
  • Past problems with brain stimulation
  • Past problems with MRI
  • Use of muscle relaxants or benzodiazepines
  • Allergy to rubbing alcohol
  • Any other health related illnesses that would prohibit a participant from physical performance testing
  • Lack of transportation to and from the laboratory
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Other
    Muscle strength condition

    Other: Action Observation

  • Other
    Muscle weakness condition

    Other: Action Observation

  • No intervention
    Control

Interventions

  • OtherAction Observation

    Strength, voluntary activation, and cortical responses to three conditions will be measured: 1) action observation of very strong, forceful contractions of the hand and wrist flexors 2) action observation of very weak, feeble contractions of the hand and wrist flexors 3) no action observation. Experimental conditions will be randomized and counterbalanced.

06

What researchers measure

Primary outcomes

  1. Muscle Strength

    Isometric muscle strength of the non-dominant hand and wrist flexors will be assessed during maximal voluntary contractions (MVCs).

    Time frame: 5 minutes

Secondary outcomes

  1. Voluntary Activation

    Percent voluntary activation will be quantified during the MVCs to determine each participant's ability to maximally activate their wrist flexor muscles voluntarily.

    Time frame: 5 minutes

  2. Corticospinal excitability

    Transcranial magnetic stimulation will be used to quantify corticospinal excitability throughout the study.

    Time frame: 5 minutes

07

Study locations

1 site
  • UCF Neuromuscular Plasticity Laboratory
    Orlando, Florida 32826, United States
08

References and documents

Publications

  • Harmon KK, Girts RM, Pagan JI, Rodriguez G, Stock MS. The acute effects of action observation on muscle strength/weakness and corticospinal excitability in older adults. Exp Brain Res. 2022 Jun;240(6):1801-1810. doi: 10.1007/s00221-022-06370-2. Epub 2022 Apr 29. PubMed 35488129 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03946709
Lead sponsor
University of Central Florida
Responsible party
Matt Stock (Assistant Professor, University of Central Florida) — Principal investigator
First posted
May 13, 2019
Start date
Dec 20, 2018
Primary completion
Mar 1, 2020
Completion
Mar 1, 2020
Last update
Jun 28, 2021

Study contacts

Matt S. Stock, Ph.D.
principal investigator · University of Central Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion